Episode 2: Leading in a crisis: Driving value for your customers, your organization, and yourself

A discussion series on Navigating Market Disruption featuring Dr. Rita Numerof and Pete Hempshall

Thursday, October 8, 2020 11:00 EST

Leadership is hard when it’s done well, and leading through a crisis or a time of transition puts even greater pressure on leadership. The pandemic has challenged pre-existing assumptions about business as usual and underlying business model fundamentals. How leaders respond to these challenges during and post-crisis will set the stage for their company’s success both in the short and longer-term.

But what makes a good leader in a crisis?

Join Numerof & Associates President and Co-Founder Dr. Rita Numerof and Deallus CEO Pete Hempshall as they explore lessons learned from navigating market disruption through client experiences, their own organizations, and as individual leaders. Rita and Pete will discuss why focus and remaining agile during and after a crisis are essential for success.

Executives looking for practical advice on how to balance agility and governance processes will want to tune in to this thought-provoking discussion.

Our hosts will explore these questions during their discussion:

  • What has the pandemic taught us about effective leadership during a crisis?

  • How can companies adapt their services in uncertain times?

  • How can leaders balance the need for agility with pre-existing and necessary governance processes?

  • How can leaders successfully steer their businesses through these and other transformative disruptions?

The hosts will take questions from the audience throughout the discussion. Registration is required to join the live webinar.
Peter Hempshall Deallus CEO
Click here to register

About the speakers

About Rita Numerof and Numeroff & Associates

Rita E. Numerof, PhD, President of Numerof & Associates, is an internationally recognized consultant and author with more than 25 years of experience in the field of strategy development and execution, business model design, and market analysis. Numerof works globally with pharmaceutical and medical device manufacturers, payers, and providers to develop and implement strategic solutions responsive to today’s dynamic business environment. Numerof helps their clients meet the challenges of development and commercialization – including strategy, market access, health economics, stakeholder analysis and value narrative development, and market evaluation.

About Peter Hempshall and Deallus

Pete Hempshall is a career consultant and business leader. Over the past twenty years, Pete has successfully led a series of global companies and strategic business units, specializing in competitive intelligence; business insights; commercial strategy and market access. Pete cut his teeth in business strategy and leadership during the financial crisis of 2008. He became CEO of Deallus, a life sciences consulting firm with a strong heritage in competitive intelligence, in 2019. Deallus works closely with pharmaceutical and biotech companies in order to offer thought partnership and strategic intelligence that shapes and refines strategies for competitive advantage.

Upcoming topics in this discussion series:

A look at what’s ahead in the Navigating Market Disruption series:

  • Learning faster than your competition

  • Maneuvering complex change in clinical trials

  • Building supply chain capabilities for the changing marketplace

  • Exploring the long-term impacts of COVID-19 on commercial models and manufacturer relationships